Jeffrey Diehl - Profile and Investment Details

Investor Profile

Jeffrey Diehl is a Private Equity Firm based in Chicago, Illinois, United States with a diverse investment portfolio that includes companies such as Arctic Wolf, Lever, Snow Software, Partner Therapeutics, Homeward, Sauce Labs, Spiceworks, Dynamic Signal, Neuraltus Pharmaceuticals, Five9, VillageMD, ThreatMetrix, Atlantis Computing, healthfinch, MATRIXX Software, Orbus Therapeutics, Corvus Pharmaceuticals, Smule, Naurex, Aptinyx, MyHealthTeams, Redox, SymphonyRM, ServiceMax, Scytl, Maxwell Health, CareCloud, Cirius Therapeutics, Cybera, GoCardless, Epirium Bio, Outpost Medicine, ThreatQuotient, Couchbase, Advise Insurance, Bluprint, cbanc Network, TurnKey Vacation Rentals, Palvella Therapeutics, Tripping.com, Borderfree, Solera Health, Q2ebanking, Chrome River Technologies, Atox Bio, Visier, Icosavax, Millendo Therapeutics, RadiumOne, TeleSign, PerimeterX, LogRhythm, Lyra Health, Apto, Damballa, Criteo, Hightail, Aircall, Qpex Biopharma, Mintigo, Punchh, Fusion Pharmaceuticals, TrendKite, BoomTown, Boundary. Over time, Jeffrey Diehl has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jeffrey Diehl is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Data Integration, Cybersecurity, Women Founded, CRM, Life Science, Artificial Intelligence (AI), Information Services, Information Technology (IT), Biotech, Analytics, Healthcare, Biotechnology, Computers, Electronic Health Records (EHR), Network Security, Employee Benefits, Insurance, Medical, Health Insurance, Therapeutics, Machine Learning, Pharmaceuticals, Biopharma, Security may find it worthwhile to explore potential connections with Jeffrey Diehl, as their portfolio suggests a familiarity and interest in this area.

Understanding Jeffrey Diehl’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.